XIDX
DAYA
Market cap201mUSD
Nov 12, Last price
1,505.00IDR
Name
Duta Intidaya Tbk PT
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
PT Duta Intidaya Tbk operates as a prominent health and beauty retailer throughout Indonesia, offering a diverse product portfolio. Its offerings span pharmaceutical products, including medicines and various pharmacy goods, alongside medical and wellness devices. The company also supplies personal care and skincare items, fragrances, cosmetics, infant products, and a selection of general merchandise. Furthermore, it engages in the trade of food and beverage items. Beyond its retail activities, PT Duta Intidaya Tbk undertakes various roles within the supply chain, serving as an agent, sole representative, distributor, purveyor, franchisor, and supplier for a wide array of traded goods. As of December 31, 2021, the company maintained a significant physical presence with 160 Watsons-branded stores spread across 14 provinces. Its digital reach is extensive, providing products through major e-commerce platforms like Shopee.com, Tokopedia.com, Lazada.com, Blibli.com, and Bukalapak.com, as well as via applications such as Halodoc, Bima+, Good Doctor, GrabMart, and GoMart. Established in 2005 and headquartered in South Jakarta, Indonesia, the company is a subsidiary of Total Alliance Holdings Limited.
Valuation
Title IDR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||